EUDA Health Holdings Limited, a Singapore‑based provider of non‑invasive healthcare and longevity services, completed a 1‑for‑20 reverse stock split of its ordinary shares. The split, effective at market open on March 23, 2026, reduces the number of shares outstanding from roughly 50.3 million to about 2.5 million, while keeping the company’s market capitalization and shareholder ownership proportions unchanged.
The reverse split is a direct response to a Nasdaq Capital Market notice received in August 2023 that the company was not meeting the exchange’s minimum bid‑price requirement of $1.00 per share. By consolidating shares, EUDA Health aims to lift its per‑share price into the $2‑$3 range that is typical for Nasdaq‑listed companies, thereby reducing the risk of a delisting action.
In addition to the share consolidation, the company will adjust its outstanding warrants in proportion to the split. The exercise price of each warrant will rise from $11.50 to $230.00, while the number of shares represented by each warrant will be reduced accordingly. No fractional shares will be issued and no cash will be paid for any fractional amounts that arise from the conversion.
EUDA Health’s management has not issued a statement explaining the split beyond the regulatory compliance rationale. The company’s business model focuses on non‑invasive diagnostics and preventive care across Singapore, Malaysia, and China, and it also operates a property‑management arm. The reverse split does not alter the company’s operational strategy but may influence investor perception, as such actions are sometimes viewed as a sign of financial distress.
The reverse split will take effect on March 23, 2026, and shareholders will receive one new share for every twenty shares held prior to the split. The adjustment is expected to maintain the overall value of shareholders’ holdings while aligning the company’s share price with Nasdaq’s listing standards.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.